Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Another European market introduction announced for emedastine

June 4, 1999

SKK-60060: new selectin inhibitor effective in animal model of retinal ischemia-reperfusion injury

June 4, 1999

Health Canada approves Cosopt glaucoma treatment

June 4, 1999

Potential new use for diphenhydramine in uveitis

June 4, 1999

VEGF TK inhibitors described by Merck for angiogenic ocular disorders

May 20, 1999

Alcon launches emedastine in U.K. for treatment of seasonal allergic conjunctivitis

May 17, 1999

Postmarketing studies of latanoprost support efficacy, safety of antiglaucoma agent

May 14, 1999

Sunrise Technologies' hyperopia treatment system scheduled for FDA advisory panel review

May 13, 1999

Spanish team develops microsphere delivery system for improved intravitreal use of corticosteroids

May 13, 1999

Cartilage-derived angiogenesis inhibitor is potentially useful in treating proliferative retinopathy

May 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...